Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)

References

• KatonWJThe comorbidity of diabetes mellitus and depressionAm J Med200812111 Suppl 2S8S1518954592
   PubMed Web of Science ®Google Scholar
• AliSStoneMAPetersJLThe prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysisDiabet Med2006231165117317054590
   PubMed Web of Science ®Google Scholar
• EgedeLENietertPJZhengDDepression and All-Cause and coronary heart disease mortality among adults with and without diabetesDiabetes Care2005281339134515920049
   PubMed Web of Science ®Google Scholar
• EgedeLEEllisCThe effects of depression on diabetes knowledge, diabetes self-management, and perceived control in indigent patients with type 2 diabetesDiabetes Technol Ther20081021321918473696
   PubMed Web of Science ®Google Scholar
• KatonWJRussoJEVon KorffMLong-term effects on medical costs of improving depression outcomes in patients with depression and diabetesDiabetes Care2008311155115918332158
   PubMed Web of Science ®Google Scholar
• DeGrootMAndersonRFreedlandKEAssociation of depression and diabetes complications: A meta-analysisPsychosom Med20016361963011485116
   PubMed Web of Science ®Google Scholar
• TalbotFNouwenAA review of the relationship between depression and diabetes in adults: is there a linkDiabetes Care2000231556156211023152
   PubMed Web of Science ®Google Scholar
• KnolMJTwiskJWBeekmanATDepression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysisDiabetologia20064983784516520921
   PubMed Web of Science ®Google Scholar
• DixonJBHaydenMJLambertGWRaised CRP levels in obese patients: symptoms of depression have an independent positive associationObesity (Silver Spring)200822(Epub ahead of print).
   Google Scholar
• DongCSanchezLEPriceRARelationship of obesity to depression: a family-based studyInt J Obesity200428790795
   PubMed Web of Science ®Google Scholar
• Russell-JonesDKhanRInsulin-associated weight gain in diabetes-causes, effects and coping strategiesDiabetes Obes Metab2007979981217924864
   PubMed Web of Science ®Google Scholar
• OnyikeCUCrumRMLeeHBIs obesity associated with major depression? Results from the third national health and nutrition examination surveyAm J Epidemiol20031581139114714652298
   PubMed Web of Science ®Google Scholar
• LustmannPJClouseRENixBDSertraline for prevention of depression recurrence in diabetes mellitusArch Gen Psychiatry20066352152916651509
   PubMed Web of Science ®Google Scholar
• GülserenLGülserenSHekimsoyZComparison of fluoxetine and paroxetine in type 2 diabetes mellitus patientsArch Med Res20053615916515847950
   PubMed Web of Science ®Google Scholar
• Diagnosis and classification of diabetes mellitus, American Diabetes AssociationDiabetes Care200629Suppl 1S43S4816373932
   PubMed Web of Science ®Google Scholar
• WhooleyMAAvinsALMirandaJCase-Finding Instrument for DepressionJ Gen Intern Med1997124394459229283
   PubMed Web of Science ®Google Scholar
• BeckATBeamesderferAAssessment of depression: the depression inventoryMod Probl Pharmacopsychiatry197471511694412100
   PubMedGoogle Scholar
• BechPRasmussenNAOlsenLRThe Sensivity and Specifity of the Major Depression Inventory, using the present State Examination as the index of diagnostic validityJ Affect Dis20018815916411578668
   PubMed Web of Science ®Google Scholar
• Austrian Diabetes AssociationTherapeutic guidelines of the Austrian Diabetes Associationhttp://www.oedg.org/pdf/Leitlinien_2007.pdf
   Google Scholar
• RushWAWhitebirdRRRushMRDepression in patients with diabetes: does it impact clinical goalsJ Am Board Fam Med20082139239718772293
   PubMed Web of Science ®Google Scholar
• GonzalezJSSafrenStACaglieroEDepression, self-care and medication adherence in type 2 diabetesDiabetes Care2007302222222717536067
   PubMed Web of Science ®Google Scholar
• LustmannPJGriffithLSFreedlandKECognitive behavioural therapy for depression in type 2 diabetes mellitusAnn Intern Med19981296136219786808
   PubMed Web of Science ®Google Scholar
• PeyrotMRubinRRBehavioral and psychosocial interventions in diabetes: A conceptual reviewDiabetes Care2007302433244017666457
   PubMed Web of Science ®Google Scholar
• LustmannPJGriffitiLSFreedlandKEFluoxetine for depression in diabetesDiabetes Care20002361862310834419
   PubMed Web of Science ®Google Scholar
• AmsterdamJDShultsJRutherfordNSafety and efficacy of s-citalopram in patients with comorbid major depression and diabetes mellitusNeuropsychobiology20075420821417337914
   PubMed Web of Science ®Google Scholar
• LustmannPJWilliamsMWSayurGSFactors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropionDiabetes Care20073045946617327305
   PubMed Web of Science ®Google Scholar
• MontgomerySATolerability of serotonin norepinephrine reuptake inhibitor antidepressantsCNS Spectr2008137(Suppl 11):273318323771
   PubMed Web of Science ®Google Scholar
• Lopez-IborJGuelfiJDPletanYMilnacipran and selective serotonin reuptake inhibitors in major depressionInt clin Psychophamacol199611Suppl 44146
   PubMed Web of Science ®Google Scholar
• ClercGMilnacipran/Fluvoxamine Study GroupAntidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamineInt Clin Psychopharmacol200116145151
   PubMed Web of Science ®Google Scholar
• SechterDVandelPWeillerEA comparative study of milnacipran and paroxetine in outpatients with major depressionJ Affect Disord20048323323615555719
   PubMed Web of Science ®Google Scholar
• OkumuraKFurukawaTARemission rates with milnacipran 100mg/day and 150 mg/day in the long-term treatment of major depressionClin Drug Invest200626135142
   Web of Science ®Google Scholar
• CiechanowskiPSKatonWJRussoJEDepression and diabetes. Impact of depressive symptoms on adherence, functions and costsArch Intern Med20001603278328511088090
   PubMed Web of Science ®Google Scholar
• Paile-HyvärinenMWahlbeckKErikssonJGQuality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trialBMC Fam Pract20034712747810
   PubMedGoogle Scholar
• GonzalezJSPeyrotMMcCarlLADepression and diabetes treatment non-adherence: A meta-analysisDiabetes Care2008312398240319033420
   PubMed Web of Science ®Google Scholar